Regulation of CYP3A4 and CYP3A5 expression and modulation of "intracrine" metabolism of androgens in prostate cells by liganded vitamin D receptor

被引:21
|
作者
Maguire, Orla [1 ]
Pollock, Catherine [1 ]
Martin, Philip [2 ]
Owen, Andrew [2 ]
Smyth, Thomas [1 ]
Doherty, Declan [1 ]
Campbell, Moray J. [3 ]
McClean, Stephen [1 ]
Thompson, Paul [1 ]
机构
[1] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland
[2] Univ Liverpool, Dept Pharmacol, Liverpool L69 3GF, Merseyside, England
[3] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
基金
英国生物技术与生命科学研究理事会;
关键词
Vitamin D receptor; Prostate; Metabolism; CYP3A4; CYP3A5; HUMAN LIVER-MICROSOMES; PREGNANE-X-RECEPTOR; CYTOCHROME-P450; 3A4; CANCER CELLS; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PROTEASE INHIBITOR; GENE POLYMORPHISMS; IN-VITRO; RISK;
D O I
10.1016/j.mce.2012.08.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We investigated the capacity for vitamin D receptor (VDR) to modulate the expression of CYP3A4 and other genes that may facilitate the oxidative inactivation of androgens such as testosterone and androstanediol within prostate cells. We report that exposure to the active hormonal form of vitamin D markedly increased gene expression of CYP3A4 and CYP3A5 and ultimately achieved levels of intracellular CYP3A enzyme activity within LNCaP prostate cancer cells that were comparable to that observed for Caco2 cells, an established model of CYP3A induction, and resulted in the increased turnover of testosterone to its inactive 6 beta-OH metabolite. We demonstrate that VDR directs CYP3A4 and CYP3A5 expression through binding to distinct regulatory motifs located within the 5' promoter regions of both genes. The current data highlight the potential application of VDR-based treatment regimes as a means to limit the bioavailability of growth-promoting androgens within the tumor microenvironment. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [21] The contribution of CYP3a4 and CYP3A5 on the metabolism of sildenafil, vardenafil, and udenafil.
    Ku, H.
    Bae, S.
    Seo, K.
    Ahn, H.
    Bae, S.
    Shon, J.
    Liu, K.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S49 - S49
  • [22] In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans
    Hirota, N
    Ito, K
    Iwatsubo, T
    Green, CE
    Tyson, CA
    Shimada, N
    Suzuki, H
    Sugiyama, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2001, 22 (02) : 53 - 71
  • [23] Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery
    Lolodi, Ogheneochukome
    Wang, Yue-Ming
    Wright, William C.
    Chen, Taosheng
    CURRENT DRUG METABOLISM, 2017, 18 (12) : 1095 - 1105
  • [24] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    A. B. Sanchez Spitman
    D. J. A. R. Moes
    H. Gelderblom
    V. O. Dezentje
    J.J. Swen
    H. J. Guchelaar
    European Journal of Clinical Pharmacology, 2017, 73 : 1589 - 1598
  • [25] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    Spitman, A. B. Sanchez
    Moes, D. J. A. R.
    Gelderblom, H.
    Dezentje, V. O.
    Swen, J. J.
    Guchelaar, H. J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1589 - 1598
  • [26] CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer
    Zeigler-Johnson, C
    Friebel, T
    Walker, AH
    Wang, YT
    Spangler, E
    Panossian, S
    Patacsil, M
    Aplenc, R
    Wein, AJ
    Malkowicz, SB
    Rebbeck, TR
    CANCER RESEARCH, 2004, 64 (22) : 8461 - 8467
  • [27] Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer
    Bellah, Sm Faysal
    Salam, Md. Abdus
    Billah, S. M. Saker
    Karim, Md Rezaul
    ANNALS OF HUMAN BIOLOGY, 2023, 50 (01) : 63 - 74
  • [28] Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
    Willrich, Maria Alice V.
    Rodrigues, Alice C.
    Cerda, Alvaro
    Genvigir, Fabiana D. V.
    Arazi, Simone S.
    Dorea, Egidio L.
    Bernik, Marcia M. S.
    Bertolami, Marcelo C.
    Faludi, Andre
    Largura, Alvaro
    Baudhuin, Linnea M.
    Bryant, Sandra C.
    Hirata, Mario Hiroyuki
    Crespo Hirata, Rosario Dominguez
    CLINICA CHIMICA ACTA, 2013, 421 : 157 - 163
  • [29] Investigation of the structural basis for the differential metabolism of glucocorticoids by CYP3A4 and CYP3A5 enzymes
    Shahrokh, Kiumars
    Yost, Garold S.
    Cheatham, Thomas E., III
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [30] Metabolism of Quetiapine by CYP3A4 and CYP3A5 in Presence or Absence of Cytochrome B5
    Bakken, Gry Vibeke
    Rudberg, Ida
    Christensen, Hege
    Molden, Espen
    Refsum, Helge
    Hermann, Monica
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (02) : 254 - 258